An alternative could be other epigenetic modifications such as hypomethylation of the SOX4 gene, as exemplified by hypomethylated Claudin4, Lipocalin2, and S100A4, which accounts for their overexpression in pancreatic cancers [53]. The gene discussed is S100A4; the disease is familial pancreatic carcinoma.